We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Streamlining Protein Therapeutics with Freeze Dryer Formulation Advance

By LabMedica International staff writers
Posted on 02 Oct 2009
For developmental scientists looking to accelerate and streamline the laborious task of developing freeze-drying cycles for protein-based therapeutics, a next-generation of freeze dryers with new technology have been developed. More...


SP Industries, Inc. (Stone Ridge, NY, USA) presented its latest innovations in freeze-drying technology at the IBC Formulation Strategies for Protein Therapeutics meeting September 2009 in Rayleigh, NC, USA. At the meeting, visitors saw how by integrating the LyoStar freeze dryer with SP Industries' Smart freeze dryer technology provides development scientists with maximum programming flexibility and product protection whether the product is processed in vials, bulk trays, 96-well plates or syringes.

The new LyoStar is designed and built like a production freeze drier, yet the size of a pilot plant model. The LyoStar has excellent shelf mapping, fast shelf freezing, stoppering for vials, ease of use, high reliability, and software that greatly reduces the average formulation development cycle time.

Smart freeze dryer technology is a patented system that puts the experience of the world's top lyophilization scientists into an easy-to-use cycle development tool. Smart freeze dryer technology enables development scientists to create a streamlined but safe process that can shave days off the production cycle. This efficiency gain can eliminate production bottlenecks, expand capacity, and reduce production costs.

SP Industries is a leading manufacturer of laboratory to production-scale freeze dryers/lyophilizers, centrifugal evaporators and concentrators, environmental control chambers, thermal control system, glassware washers and dryers. The company markets its products under well-known brands including Hotpack, VirTis, FTS, and Genevac. SP Industries has ISO 9001:2000 registered production facilities in the United States and Europe.

Related Links:

SP Industries



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Immunofluorescence Analyzer
IFA System
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Graphical abstract (Pola, I., Akinyemi, T., Tan, K. et al. Nature Communications(2026). https://doi.org/10.1038/s41467-026-74971-4)

Blood Biomarker Study Reveals Population-Specific Differences in Alzheimer’s Disease

Blood-based biomarkers are emerging as tools for detecting Alzheimer’s disease–related changes without relying on advanced brain imaging or cerebrospinal fluid (CSF) analysis. However, much of the foundational... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test for Lung Cancer Screening Receives FDA Breakthrough Device Designation

Lung cancer remains the leading cause of cancer death in the United States, yet only about 18% of people eligible for screening undergo low-dose computed tomography, the current guideline-recommended method.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.